Freteluco v. Smith's Food and Drug Centers, Inc.

District Court, D. Nevada·Decided July 13, 2021·No. 2:19-cv-00759·Unknown

Opinion

3 * * *

4 ANNA MARIE FRETELUCO, Case No. 2:19-cv-00759-JCM-EJY

5 Plaintiff,

6 v. ORDER

INC., a foreign corporation; DOES 1-10; ROE 8 CORPORAITONS 1-10; inclusive,

9 Defendants.

10 11 Pending before the Court is Defendant’s Motion to Strike/Exclude Plaintiff’s Damages for 12 Future Medical Expenses. ECF No. 65. The Court has considered Defendant’s Motion, Plaintiff’s 13 Response (ECF No. 70), and the Defendant’s Reply. ECF No. 72. The Court finds as follows. 14 I. Background 15 The striking of Plaintiff’s future damages was the subject of a prior hearing, Order, 16 Objection, and Affirmation of the Order by District Judge Mahan. ECF Nos. 35-37, 39, and 47. 17 Defendant argues that the instant Motion is based on new grounds—that the damages are speculative. 18 ECF No. 65 at 2. Defendant states that Plaintiff is no longer treating for her alleged Traumatic Brain 19 Injury (“TBI”) because an email sent by Plaintiff’s counsel states Plaintiff “has and is receiving all 20 the necessary treatment for her condition.” Id. at 3 n.5 citing Exhibit A. Defendant contends because 21 Plaintiff has allegedly received all the treatment she is ever going to receive for her TBI, the only 22 future treatment Plaintiff may require would be for her neck. Id. at 3. According to Defendant, the 23 only evidence Plaintiff provided regarding neck issues arises “from a single visit … with Dr. Jason 24 Garber” in October 2019, at which time “Dr. Garber recommended injections to two levels of 25 Plaintiff’s cervical spine.” Id. Defendant states these injections never took place. Id. Neither Dr. 26 Garber, nor any other health care professional, nor retained expert “supports the $500,000 amount 27 of future medical expenses.” Id. Pointing to Plaintiff’s 11th Supplemental Disclosure (the date of 1 identified any other medical treatment performed after December 17, 2019, nor has she ever 2 indicated what other treatment will be performed in the future to justify claiming $500,000 in future 3 expenses.” Id. at 4. 4 Returning to arguments made in several motions prior to the one at bar, Defendant also argues 5 that it was not until Plaintiff’s third supplement to her Rule 26 disclosures, on December 12, 2019, 6 that she included estimated “future medical expenses” of $500,000.00. Id. at 5. Defendant states 7 Plaintiff does not support this number with a calculation explaining the basis for these future medical 8 costs, and provides no document from a health care provider “setting forth what specific care 9 Plaintiff will require in the future ….” Id. 10 Plaintiff, as she has done before, summarizes her medical treatment (ECF No. 70 at 3-5), 11 quotes Fed. R. Civ. P. 26, and states that: (1) Nevada law does not require future damages to be 12 certain until the date of trial; and (2) future damages may be based on testimony at the trial. Id. at 6 13 citing Yamaha Motor Co. v. Arnoult, 955 P.2d 661 (Nev. 1998). Plaintiff further argues that, because 14 she continues to treat with physical therapy, neurology, and speech pathology, her future damages 15 “disclosure is just that, an estimate … meant to put the Defense on notice of the fact that Plaintiff 16 expects to have future damages but does not know the exact amount.” Id. at 7. Plaintiff concludes 17 her Response by stating that the fact that future damages “are still speculative is okay” and that 18 “Plaintiff is not required to follow the Defense’s timeline for her medical treatment!” Id. (Emphasis 19 in original.) 20 Defendant replies stating that “future medical expenses must be supported by sufficient and 21 competent evidence … [establishing] a reasonable probability that such expenses will be incurred.” 22 ECF No. 74 at 2-3. Distinguishing Yamaha, Defendant argues that the plaintiff’s experts in that case 23 had opined in reports about the need and basis for future medical treatment; whereas, in this case no 24 expert has offered any opinion, to date, supporting a need for future medical care even approaching 25 $500,000. Id. at 3. 26 II. Discussion 27 Federal Rule of Civil Procedure 26(a)(1)(A)(iii) states “a party must … provide to the other 1 also make available for inspection and copying … the documents or other evidentiary material … 2 on which each computation is based ….” Although initial disclosures are due 14 days after the 3 parties hold an original Rule 26(f) conference, Rule 26(e)(1) allows supplementation of incomplete 4 or incorrect disclosures throughout the discovery process. “The disclosure requirements of Rule 5 26(a)(1)(A) are designed to accelerate ‘the exchange of basic information that is needed in most 6 cases to prepare for trial or make an informed decision about settlement.’” Jones v. Wal-Mart Stores, 7 Inc., Case No. 2:15-cv-1454-LDG-GWF, 2016 WL 1248707, at *3 (D. Nev. Mar. 28. 2016) citing 8 Advisory Committee Notes to 1993 Amendments to Fed. R. Civ. P. 26(a). As explained by Judge 9 Foley (Ret.) in Jones:

10 A plaintiff’s computation of damages should provide sufficient detail to enable the defendant to understand the contours of its potential exposure and make informed 11 decisions regarding settlement and discovery … The word computation contemplates some analysis beyond merely setting forth a lump sum amount for a 12 claimed element of damages. … A plaintiff should disclose the basic method or formula by which it contends its damages should or will be calculated even if it 13 cannot identify the specific dollar amount of damages pending further discovery. … The disclosure should be more specific and in greater detail, the closer it is made 14 to the end of discovery and the trial date. 15 Id. (internal citations and quotation marks omitted). 16 Moreover, keeping common sense in mind, the District of Nevada previously held that “Rule 17 26(a)(1)(A)(iii) would be rendered meaningless if a party could avoid its requirements by not 18 obtaining the documents or information needed to prepare the damages computation.” Jackson v. 19 United Artists Theatre Circuit, Inc., 278 F.R.D. 586, 594 (D. Nev. 2011). 20 Federal Rule of Civil Procedure 37(c)(1) states, in pertinent part, that “[i]f a party fails to 21 provide information … as required by Rule 26(a) or (e), the party is not allowed to use that 22 information … to supply evidence on a motion, at a hearing, or at a trial, unless the failure was 23 substantially justified or it harmless.” This Rule allow that in place of striking the information from 24 use, a court may grant other sanctions such as an award of attorney’s fees and costs, providing the 25 jury with information about the party’s failure or any other sanction listed in Rule 37(b)(2)(A)(i)- 26 (vi). “Courts are more likely to exclude damages evidence when a party first discloses its 27 computation of damages shortly before trial or substantially after discovery has closed.” Martin v. 1 Jackson, 278 F.R.D. at 594 (other internal citations omitted). The court in Martin also explained 2 that “[t]ypically, a medical expert witness will provide an estimate for the cost of future …[care] 3 that he believes the plaintiff will need as a result of his accident injuries.” Id. at *3.1 4 The burden is on the disclosing party to demonstrate that the failure to disclose information 5 required to be disclosed by Rule 26 was justified or harmless under Rule 37. Yeti by Molly Ltd. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Freteluco v. Smith's Food and Drug Centers, Inc., (D. Nev. 2021).

Freteluco v. Smith's Food and Drug Centers, Inc. (Freteluco v. Smith's Food and Drug Centers, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related